News
To announce the expected date of the board of directors meeting to approve the consolidated financial statements is 2025/08/04 for the second quarter of 2025
2025.7.25
...
More
TSH Biopharm Wins Dual Honors at the 2025 AREA Asia Responsible Enterprise Awards
2025.6.27
...
More
TSH Biopharm was invited to attend the online institutional investor conference hosted by Concord Securities
2025.6.2
...
More
Important resolutions of the Company's 2025 General Shareholders' Meeting
2025.5.28
...
More
Announcement of the Ex-dividend Record Date of Cash Dividends
2025.5.28
...
More
Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD., regarding the release of non-competition restrictions for Directors
2025.5.20
...
More